Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026)
Sol-Gel Technologies (SLGL) reported EPS (Basic) of $1.31 for Q1 2026, down 59.06% year-over-year from $3.2 in Q1 2025, and up 223.58% quarter-over-quarter from -$1.06 in Q4 2025.
Sol-Gel Technologies (SLGL) EPS (Basic) (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of EPS (Basic) data on file, last reported at $1.31 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at $1.31, down 59.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.29 (up 35.5% YoY), and the FY2025 annual result was -$2.19, up 42.22% from the prior year.
- EPS (Basic) climbed to $1.31 in Q1 2026 per SLGL's latest filing, from -$1.06 in the prior quarter.
- Over five years, EPS (Basic) peaked at $4.17 in Q2 2025 and troughed at -$9.17 in Q4 2023.
- A 5-year average of -$0.18 and a median of -$0.13 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) slumped 3568.0% in 2023, then jumped 487.32% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.25 in 2022, then tumbled by 3568.0% to -$9.17 in 2023, then jumped by 77.21% to -$2.09 in 2024, then soared by 49.28% to -$1.06 in 2025, then soared by 223.58% to $1.31 in 2026.
- Business Quant data shows SLGL's EPS (Basic) at $1.31 in Q1 2026, -$1.06 in Q4 2025, and -$2.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 1.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | -1.06 |
| Sep 30, 2025 | -2.13 |
| Jun 30, 2025 | 4.17 |
| Mar 31, 2025 | 3.20 |
| Dec 31, 2024 | -2.09 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 2.30 |
| Dec 31, 2023 | -9.17 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.22 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | -0.25 |
| Sep 30, 2022 | -0.15 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.24 |
| Dec 31, 2021 | 0.61 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.35 |